Neumora Therapeutics, Inc. Contracts & Agreements

38 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Executive Chairman Agreement, dated as of July 3, 2023, by and between the Registrant and Paul L. Berns
Neumora Therapeutics, Inc.
2023
Second Amendment to License Agreement, dated May 17, 2024, by and between the Registrant and Vanderbilt University
License Agreements
Neumora Therapeutics, Inc.
2024
Non-Employee Director Compensation Program
Compensation Agreements
Neumora Therapeutics, Inc.
2024
RBNC Therapeutics, Inc. Milestone Carveout Plan
Neumora Therapeutics, Inc.
2024
Executive Employment Agreement, dated as of November 13, 2023, by and between the Registrant and Jason Duncan
Employment Agreements
Neumora Therapeutics, Inc.
2024
Executive Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Carol Y. Suh
Employment Agreements
Neumora Therapeutics, Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Neumora Therapeutics, Inc.
2023
Form of Common Stock Certificate
Stock Agreements
Neumora Therapeutics, Inc.
2023
First Amendment to Exclusive License Agreement for GCase, dated June 14, 2022, by and between the Registrant and Amgen, Inc
License Agreements
Neumora Therapeutics, Inc.
2023
Form of Indemnification and Advancement Agreement for directors and officers
Indemnification Agreements
Neumora Therapeutics, Inc.
2023
Non-Employee Director Compensation Program
Compensation Agreements
Neumora Therapeutics, Inc.
2023
Employment Agreement by and between the Registrant and Joshua Pinto, Ph.D
Employment Agreements
Neumora Therapeutics, Inc.
2023
Non-Employee Director Compensation Program
Compensation Agreements
Neumora Therapeutics, Inc.
2023
License Agreement, dated February 10, 2022, by and between the Registrant and Vanderbilt University
License Agreements
Neumora Therapeutics, Inc.
2023
First Amendment to License Agreement, dated July 17, 2023, by and between the Registrant and Vanderbilt University
License Agreements
Neumora Therapeutics, Inc.
2023
Form of Executive Employment Agreement
Employment Agreements
Neumora Therapeutics, Inc.
2023
Form of Executive Employment Agreement for Chief Executive Officer
Employment Agreements
Neumora Therapeutics, Inc.
2023
Separation Agreement by and between the Registrant and John Dunlop, Ph.D
Separation Agreements
Neumora Therapeutics, Inc.
2023
Consulting Agreement, dated as of May 20, 2023, by and between the Registrant and John Dunlop, Ph.D
Consulting Agreements
Neumora Therapeutics, Inc.
2023
Executive Employment Agreement, dated as of June 2, 2023, by and between the Registrant and Henry O. Gosebruch
Employment Agreements
Neumora Therapeutics, Inc.
2023
Agreement and Plan of Merger, dated June 1, 2020, by and among the Registrant, Berries Merger Sub, Inc, BlackThorn Therapeutics, Inc. and Fortis Advisors LLC
Merger Agreements
Neumora Therapeutics, Inc.
2023
Agreement and Plan of Merger, dated November 24, 2020, by and among the Registrant, Alairion Merger Sub I, Inc, Alairion Merger Sub II, LLC, Alairion, Inc. and John F. Lee
Merger Agreements
Neumora Therapeutics, Inc.
2023
Investors Rights Agreement, dated September 22, 2022, by and among the Registrant and the investors listed therein
Investor Rights Agreements
Neumora Therapeutics, Inc.
2023
Research Collaboration and License Agreement, dated September 10, 2021, by and between the Registrant and Amgen Inc
Collaboration Agreements
Neumora Therapeutics, Inc.
2023
Exclusive License Agreement for CK1d, dated September 10, 2021, by and between the Registrant and Amgen Inc
License Agreements
Neumora Therapeutics, Inc.
2023
Exclusive License Agreement for GCase, dated September 10, 2021, by and between the Registrant and Amgen Inc
License Agreements
Neumora Therapeutics, Inc.
2023
License Agreement, dated November 23, 2015, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute
License Agreements
Neumora Therapeutics, Inc.
2023
First Amendment to License Agreement, dated November 13, 2017, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute
License Agreements
Neumora Therapeutics, Inc.
2023
Second Amendment to License Agreement, dated April 9, 2019, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute
License Agreements
Neumora Therapeutics, Inc.
2023
2020 Equity Incentive Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
Form of Stock Option Agreement under the 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
Form of Restricted Stock Purchase Agreement under the 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
2023 Incentive Award Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Incentive Award Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2023 Incentive Award Plan
Bonus & Incentive Agreements
Neumora Therapeutics, Inc.
2023
Employee Stock Purchase Plan
Stock Agreements
Neumora Therapeutics, Inc.
2023
Employment Agreement by and between the Registrant and Paul L. Berns
Employment Agreements
Neumora Therapeutics, Inc.
2023
Employment Agreement by and between the Registrant and John Dunlop, Ph.D
Employment Agreements
Neumora Therapeutics, Inc.
2023